1401901-15-2

Upstream product

• 193152-99-7 (2R,3R)-2-(3-Cyano-benzyl)-3-(4-pyridin-4-yl-benzoylamino)-butyric acid methyl ester 
• 1263065-69-5 C₇H₆O₂*C₁₃H₁₆N₂O₂ 
• 28188-41-2 m-(bromomethyl)benzonitrile 
• 409081-12-5 (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester hydrochloride 
• 532-32-1 sodium benzoate 

Relevant academic research and scientific papers

BENZOIC ACID SALT OF OTAMIXABAN

The invention relates to a benzoic acid salt of methyl (2R,3R)-2-{3-[amino (imino) methyl]benzyl}-3-{[4-(1 -oxidopyridin-4-yl)benzoyl]amino}butanoate, and to a benzoic acid salt of methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1 -oxidopyridin-4- yl)benzoyl]amino}butanoate which is in a crystalline form or in at least partially crystalline form, as well as a process for the preparation of the same, methods of using such salt to treat subjects suffering from conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.